These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 10600691)
1. Searching for drug targets in microbial genomes. Galperin MY; Koonin EV Curr Opin Biotechnol; 1999 Dec; 10(6):571-8. PubMed ID: 10600691 [TBL] [Abstract][Full Text] [Related]
2. Bacterial targets and antibiotics: genome-based drug discovery. Gray CP; Keck W Cell Mol Life Sci; 1999 Nov; 56(9-10):779-87. PubMed ID: 11212338 [TBL] [Abstract][Full Text] [Related]
3. [Role of drug efflux pumps in bacterial multidrug resistance and virulence. Analysis to identify novel drug targets and counteract multidrug resistance and virulence]. Nishino K Jpn J Antibiot; 2008 Apr; 61(2):105-13. PubMed ID: 18669419 [No Abstract] [Full Text] [Related]
4. Completely sequenced genomes of pathogenic bacteria: a review. Guzmán E; Romeu A; Garcia-Vallve S Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):88-98. PubMed ID: 18341921 [TBL] [Abstract][Full Text] [Related]
5. Current Advances in the Identification and Characterization of Putative Drug and Vaccine Targets in the Bacterial Genomes. Shahbaaz M; Bisetty K; Ahmad F; Hassan MI Curr Top Med Chem; 2016; 16(9):1040-69. PubMed ID: 26303422 [TBL] [Abstract][Full Text] [Related]
12. Crystallizing new approaches for antimicrobial drug discovery. Schmid MB Biochem Pharmacol; 2006 Mar; 71(7):1048-56. PubMed ID: 16458857 [TBL] [Abstract][Full Text] [Related]
13. Do we need new antibiotics? The search for new targets and new compounds. Spížek J; Novotná J; Rezanka T; Demain AL J Ind Microbiol Biotechnol; 2010 Dec; 37(12):1241-8. PubMed ID: 21086099 [TBL] [Abstract][Full Text] [Related]
14. [Two-component signal transduction as attractive drug targets in pathogenic bacteria]. Utsumi R; Igarashi M Yakugaku Zasshi; 2012; 132(1):51-8. PubMed ID: 22214580 [TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial agents in the future. The contribution of genomics to their design]. Egorov AM; Sazykin IuO Antibiot Khimioter; 1999; 44(12):5-14. PubMed ID: 10687027 [No Abstract] [Full Text] [Related]
17. Can virulence factors be viable antibacterial targets? Marra A Expert Rev Anti Infect Ther; 2004 Feb; 2(1):61-72. PubMed ID: 15482172 [TBL] [Abstract][Full Text] [Related]
18. Bacterial virulence as a target for antimicrobial chemotherapy. Alksne LE; Projan SJ Curr Opin Biotechnol; 2000 Dec; 11(6):625-36. PubMed ID: 11102800 [TBL] [Abstract][Full Text] [Related]
19. Contribution of genomics to bacterial pathogenesis. Field D; Hood D; Moxon R Curr Opin Genet Dev; 1999 Dec; 9(6):700-3. PubMed ID: 10607606 [TBL] [Abstract][Full Text] [Related]
20. Predicting conserved essential genes in bacteria: in silico identification of putative drug targets. Duffield M; Cooper I; McAlister E; Bayliss M; Ford D; Oyston P Mol Biosyst; 2010 Dec; 6(12):2482-9. PubMed ID: 20949199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]